Health · 1 sources covering this

STAT+: Brain organoids, kept alive more than five years, matured like human brains

Brain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic signatures like those of human brains.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Brain organoids, kept alive more than five years, matured like human brains
Brain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic signatures like those of human brains.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/6ee103f81fb1b68b9834a31c555e73db6bd6f6fc"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Brain organoids, kept alive more than five years, matured like human brains"></iframe>

STAT+: Brain organoids, kept alive more than five years, matured like human brains

How 1 sources are covering this

STAT+: Brain organoids, kept alive more than five years, matured like human brains

More from Health

Real-world study of Oregon's nonmedical psilocybin program shows promise

STAT+: American Cancer Society cancels alcohol industry fundraiser

STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more

Dissecting Chinese trial strategy in wake of deaths

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Brain organoids, kept alive more than five years, matured like human brains

More from Health

Real-world study of Oregon's nonmedical psilocybin program shows promise

STAT+: American Cancer Society cancels alcohol industry fundraiser

STAT+: Pharmalittle: We&#8217;re reading about an FDA commish nominee, mRNA cancer vaccine results, and more

Dissecting Chinese trial strategy in wake of deaths

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more